The global Menopause Drugs market is projected to grow from US$ 10160 million in 2024 to US$ 11850 million by 2030, at a Compound Annual Growth Rate (CAGR) of 2.6% during the forecast period.

Menopause Drugs Market

Menopause is the end of a woman’s menstrual cycles. The term can describe any of the changes you go through just before or after you stop having your period, marking the end of your reproductive years.

Market Analysis and Insights: Global Menopause Drugs Market

The menopause drugs market is primarily driven by the increasing aging population of women and the growing awareness of menopausal symptoms and their management. As women approach menopause, they often experience symptoms like hot flashes, mood swings, and sleep disturbances, leading to a rising demand for effective treatments. Hormone replacement therapy (HRT) and non-hormonal drugs are commonly prescribed to alleviate these symptoms, contributing to market growth. However, challenges in this market include concerns related to the long-term use of hormone therapy, potential side effects, and the need for personalized treatment plans. There is ongoing research to develop safer and more tailored therapies for menopausal symptom management. Additionally, cultural and societal factors can influence the acceptance and utilization of menopause drugs, making it important for pharmaceutical companies to address these aspects to succeed in the market.

Report Covers:

This report presents an overview of global market for Menopause Drugs market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Menopause Drugs, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Menopause Drugs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Menopause Drugs revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Menopause Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Menopause Drugs revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Menopause Drugs Market Report

Report Metric	Details
Report Name	Menopause Drugs Market
Accounted market size in 2024	US$ 10160 million
Forecasted market size in 2030	US$ 11850 million
CAGR	2.6
Base Year	2024
Forecasted years	2025 - 2030
Segment by Type	Parenteral Transdermal Oral Others
Segment by Application	Hospitals Drugstores Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Eli Lilly, Pfizer, AbbVie, Novo Nordisk, Merck KGaA, Viatris, Bayer, Teva, Novartis, Abbott, Roche, Endo International, Ipsen
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Menopause Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Menopause Drugs companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Menopause Drugs revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Menopause Drugs Market growing?

Ans: The Menopause Drugs Market witnessing a CAGR of 2.6 during the forecast period 2025-2030.

What is the Menopause Drugs Market size in 2030?

Ans: The Menopause Drugs Market size in 2030 will be US$ 11850 million.

Who are the main players in the Menopause Drugs Market report?

Ans: The main players in the Menopause Drugs Market are Eli Lilly, Pfizer, AbbVie, Novo Nordisk, Merck KGaA, Viatris, Bayer, Teva, Novartis, Abbott, Roche, Endo International, Ipsen

What are the Application segmentation covered in the Menopause Drugs Market report?

Ans: The Applications covered in the Menopause Drugs Market report are Hospitals, Drugstores, Others

What are the Type segmentation covered in the Menopause Drugs Market report?

Ans: The Types covered in the Menopause Drugs Market report are Parenteral, Transdermal, Oral, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Menopause Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Parenteral

1.2.3 Transdermal

1.2.4 Oral

1.2.5 Others

1.3 Market by Application

1.3.1 Global Menopause Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Hospitals

1.3.3 Drugstores

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Menopause Drugs Market Perspective (2019-2030)

2.2 Global Menopause Drugs Growth Trends by Region

2.2.1 Menopause Drugs Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Menopause Drugs Historic Market Size by Region (2019-2024)

2.2.3 Menopause Drugs Forecasted Market Size by Region (2025-2030)

2.3 Menopause Drugs Market Dynamics

2.3.1 Menopause Drugs Industry Trends

2.3.2 Menopause Drugs Market Drivers

2.3.3 Menopause Drugs Market Challenges

2.3.4 Menopause Drugs Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Menopause Drugs by Players

3.1.1 Global Menopause Drugs Revenue by Players (2019-2024)

3.1.2 Global Menopause Drugs Revenue Market Share by Players (2019-2024)

3.2 Global Menopause Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Menopause Drugs, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Menopause Drugs Market Concentration Ratio

3.4.1 Global Menopause Drugs Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Menopause Drugs Revenue in 2023

3.5 Global Key Players of Menopause Drugs Head office and Area Served

3.6 Global Key Players of Menopause Drugs, Product and Application

3.7 Global Key Players of Menopause Drugs, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Menopause Drugs Breakdown Data by Type

4.1 Global Menopause Drugs Historic Market Size by Type (2019-2024)

4.2 Global Menopause Drugs Forecasted Market Size by Type (2025-2030)

5 Menopause Drugs Breakdown Data by Application

5.1 Global Menopause Drugs Historic Market Size by Application (2019-2024)

5.2 Global Menopause Drugs Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Menopause Drugs Market Size (2019-2030)

6.2 North America Menopause Drugs Market Size by Type

6.2.1 North America Menopause Drugs Market Size by Type (2019-2024)

6.2.2 North America Menopause Drugs Market Size by Type (2025-2030)

6.2.3 North America Menopause Drugs Market Share by Type (2019-2030)

6.3 North America Menopause Drugs Market Size by Application

6.3.1 North America Menopause Drugs Market Size by Application (2019-2024)

6.3.2 North America Menopause Drugs Market Size by Application (2025-2030)

6.3.3 North America Menopause Drugs Market Share by Application (2019-2030)

6.4 North America Menopause Drugs Market Size by Country

6.4.1 North America Menopause Drugs Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Menopause Drugs Market Size by Country (2019-2024)

6.4.3 North America Menopause Drugs Market Size by Country (2025-2030)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Menopause Drugs Market Size (2019-2030)

7.2 Europe Menopause Drugs Market Size by Type

7.2.1 Europe Menopause Drugs Market Size by Type (2019-2024)

7.2.2 Europe Menopause Drugs Market Size by Type (2025-2030)

7.2.3 Europe Menopause Drugs Market Share by Type (2019-2030)

7.3 Europe Menopause Drugs Market Size by Application

7.3.1 Europe Menopause Drugs Market Size by Application (2019-2024)

7.3.2 Europe Menopause Drugs Market Size by Application (2025-2030)

7.3.3 Europe Menopause Drugs Market Share by Application (2019-2030)

7.4 Europe Menopause Drugs Market Size by Country

7.4.1 Europe Menopause Drugs Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Menopause Drugs Market Size by Country (2019-2024)

7.4.3 Europe Menopause Drugs Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Menopause Drugs Market Size (2019-2030)

8.2 China Menopause Drugs Market Size by Type

8.2.1 China Menopause Drugs Market Size by Type (2019-2024)

8.2.2 China Menopause Drugs Market Size by Type (2025-2030)

8.2.3 China Menopause Drugs Market Share by Type (2019-2030)

8.3 China Menopause Drugs Market Size by Application

8.3.1 China Menopause Drugs Market Size by Application (2019-2024)

8.3.2 China Menopause Drugs Market Size by Application (2025-2030)

8.3.3 China Menopause Drugs Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Menopause Drugs Market Size (2019-2030)

9.2 Asia Menopause Drugs Market Size by Type

9.2.1 Asia Menopause Drugs Market Size by Type (2019-2024)

9.2.2 Asia Menopause Drugs Market Size by Type (2025-2030)

9.2.3 Asia Menopause Drugs Market Share by Type (2019-2030)

9.3 Asia Menopause Drugs Market Size by Application

9.3.1 Asia Menopause Drugs Market Size by Application (2019-2024)

9.3.2 Asia Menopause Drugs Market Size by Application (2025-2030)

9.3.3 Asia Menopause Drugs Market Share by Application (2019-2030)

9.4 Asia Menopause Drugs Market Size by Region

9.4.1 Asia Menopause Drugs Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Menopause Drugs Market Size by Region (2019-2024)

9.4.3 Asia Menopause Drugs Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Menopause Drugs Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Menopause Drugs Market Size by Type

10.2.1 Middle East, Africa, and Latin America Menopause Drugs Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Menopause Drugs Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Menopause Drugs Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Menopause Drugs Market Size by Application

10.3.1 Middle East, Africa, and Latin America Menopause Drugs Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Menopause Drugs Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Menopause Drugs Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Menopause Drugs Market Size by Country

10.4.1 Middle East, Africa, and Latin America Menopause Drugs Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Menopause Drugs Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Menopause Drugs Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Eli Lilly

11.1.1 Eli Lilly Company Details

11.1.2 Eli Lilly Business Overview

11.1.3 Eli Lilly Menopause Drugs Introduction

11.1.4 Eli Lilly Revenue in Menopause Drugs Business (2019-2024)

11.1.5 Eli Lilly Recent Developments

11.2 Pfizer

11.2.1 Pfizer Company Details

11.2.2 Pfizer Business Overview

11.2.3 Pfizer Menopause Drugs Introduction

11.2.4 Pfizer Revenue in Menopause Drugs Business (2019-2024)

11.2.5 Pfizer Recent Developments

11.3 AbbVie

11.3.1 AbbVie Company Details

11.3.2 AbbVie Business Overview

11.3.3 AbbVie Menopause Drugs Introduction

11.3.4 AbbVie Revenue in Menopause Drugs Business (2019-2024)

11.3.5 AbbVie Recent Developments

11.4 Novo Nordisk

11.4.1 Novo Nordisk Company Details

11.4.2 Novo Nordisk Business Overview

11.4.3 Novo Nordisk Menopause Drugs Introduction

11.4.4 Novo Nordisk Revenue in Menopause Drugs Business (2019-2024)

11.4.5 Novo Nordisk Recent Developments

11.5 Merck KGaA

11.5.1 Merck KGaA Company Details

11.5.2 Merck KGaA Business Overview

11.5.3 Merck KGaA Menopause Drugs Introduction

11.5.4 Merck KGaA Revenue in Menopause Drugs Business (2019-2024)

11.5.5 Merck KGaA Recent Developments

11.6 Viatris

11.6.1 Viatris Company Details

11.6.2 Viatris Business Overview

11.6.3 Viatris Menopause Drugs Introduction

11.6.4 Viatris Revenue in Menopause Drugs Business (2019-2024)

11.6.5 Viatris Recent Developments

11.7 Bayer

11.7.1 Bayer Company Details

11.7.2 Bayer Business Overview

11.7.3 Bayer Menopause Drugs Introduction

11.7.4 Bayer Revenue in Menopause Drugs Business (2019-2024)

11.7.5 Bayer Recent Developments

11.8 Teva

11.8.1 Teva Company Details

11.8.2 Teva Business Overview

11.8.3 Teva Menopause Drugs Introduction

11.8.4 Teva Revenue in Menopause Drugs Business (2019-2024)

11.8.5 Teva Recent Developments

11.9 Novartis

11.9.1 Novartis Company Details

11.9.2 Novartis Business Overview

11.9.3 Novartis Menopause Drugs Introduction

11.9.4 Novartis Revenue in Menopause Drugs Business (2019-2024)

11.9.5 Novartis Recent Developments

11.10 Abbott

11.10.1 Abbott Company Details

11.10.2 Abbott Business Overview

11.10.3 Abbott Menopause Drugs Introduction

11.10.4 Abbott Revenue in Menopause Drugs Business (2019-2024)

11.10.5 Abbott Recent Developments

11.11 Roche

11.11.1 Roche Company Details

11.11.2 Roche Business Overview

11.11.3 Roche Menopause Drugs Introduction

11.11.4 Roche Revenue in Menopause Drugs Business (2019-2024)

11.11.5 Roche Recent Developments

11.12 Endo International

11.12.1 Endo International Company Details

11.12.2 Endo International Business Overview

11.12.3 Endo International Menopause Drugs Introduction

11.12.4 Endo International Revenue in Menopause Drugs Business (2019-2024)

11.12.5 Endo International Recent Developments

11.13 Ipsen

11.13.1 Ipsen Company Details

11.13.2 Ipsen Business Overview

11.13.3 Ipsen Menopause Drugs Introduction

11.13.4 Ipsen Revenue in Menopause Drugs Business (2019-2024)

11.13.5 Ipsen Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

List of Tables

Table 1. Global Menopause Drugs Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of Parenteral

Table 3. Key Players of Transdermal

Table 4. Key Players of Oral

Table 5. Key Players of Others

Table 6. Global Menopause Drugs Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 7. Global Menopause Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Menopause Drugs Market Size by Region (2019-2024) & (US$ Million)

Table 9. Global Menopause Drugs Market Share by Region (2019-2024)

Table 10. Global Menopause Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 11. Global Menopause Drugs Market Share by Region (2025-2030)

Table 12. Menopause Drugs Market Trends

Table 13. Menopause Drugs Market Drivers

Table 14. Menopause Drugs Market Challenges

Table 15. Menopause Drugs Market Restraints

Table 16. Global Menopause Drugs Revenue by Players (2019-2024) & (US$ Million)

Table 17. Global Menopause Drugs Revenue Share by Players (2019-2024)

Table 18. Global Top Menopause Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Menopause Drugs as of 2023)

Table 19. Global Menopause Drugs Industry Ranking 2022 VS 2023 VS 2024

Table 20. Global 5 Largest Players Market Share by Menopause Drugs Revenue (CR5 and HHI) & (2019-2024)

Table 21. Global Key Players of Menopause Drugs, Headquarters and Area Served

Table 22. Global Key Players of Menopause Drugs, Product and Application

Table 23. Global Key Players of Menopause Drugs, Product and Application

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Menopause Drugs Market Size by Type (2019-2024) & (US$ Million)

Table 26. Global Menopause Drugs Revenue Market Share by Type (2019-2024)

Table 27. Global Menopause Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 28. Global Menopause Drugs Revenue Market Share by Type (2025-2030)

Table 29. Global Menopause Drugs Market Size by Application (2019-2024) & (US$ Million)

Table 30. Global Menopause Drugs Revenue Share by Application (2019-2024)

Table 31. Global Menopause Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 32. Global Menopause Drugs Revenue Share by Application (2025-2030)

Table 33. North America Menopause Drugs Market Size by Type (2019-2024) & (US$ Million)

Table 34. North America Menopause Drugs Market Size by Type (2025-2030) & (US$ Million)

Table 35. North America Menopause Drugs Market Size by Application (2019-2024) & (US$ Million)

Table 36. North America Menopause Drugs Market Size by Application (2025-2030) & (US$ Million)

Table 37. North America Menopause Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. North America Menopause Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 39. North America Menopause Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 40. Europe Menopause Drugs Market Size by Type (2019-2024) & (US$ Million)

Table 41. Europe Menopause Drugs Market Size by Type (2025-2030) & (US$ Million)

Table 42. Europe Menopause Drugs Market Size by Application (2019-2024) & (US$ Million)

Table 43. Europe Menopause Drugs Market Size by Application (2025-2030) & (US$ Million)

Table 44. Europe Menopause Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Europe Menopause Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 46. Europe Menopause Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 47. China Menopause Drugs Market Size by Type (2019-2024) & (US$ Million)

Table 48. China Menopause Drugs Market Size by Type (2025-2030) & (US$ Million)

Table 49. China Menopause Drugs Market Size by Application (2019-2024) & (US$ Million)

Table 50. China Menopause Drugs Market Size by Application (2025-2030) & (US$ Million)

Table 51. Asia Menopause Drugs Market Size by Type (2019-2024) & (US$ Million)

Table 52. Asia Menopause Drugs Market Size by Type (2025-2030) & (US$ Million)

Table 53. Asia Menopause Drugs Market Size by Application (2019-2024) & (US$ Million)

Table 54. Asia Menopause Drugs Market Size by Application (2025-2030) & (US$ Million)

Table 55. Asia Menopause Drugs Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 56. Asia Menopause Drugs Market Size by Region (2019-2024) & (US$ Million)

Table 57. Asia Menopause Drugs Market Size by Region (2025-2030) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Menopause Drugs Market Size by Type (2019-2024) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Menopause Drugs Market Size by Type (2025-2030) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Menopause Drugs Market Size by Application (2019-2024) & (US$ Million)

Table 61. Middle East, Africa, and Latin America Menopause Drugs Market Size by Application (2025-2030) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Menopause Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 63. Middle East, Africa, and Latin America Menopause Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 64. Middle East, Africa, and Latin America Menopause Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 65. Eli Lilly Company Details

Table 66. Eli Lilly Business Overview

Table 67. Eli Lilly Menopause Drugs Product

Table 68. Eli Lilly Revenue in Menopause Drugs Business (2019-2024) & (US$ Million)

Table 69. Eli Lilly Recent Developments

Table 70. Pfizer Company Details

Table 71. Pfizer Business Overview

Table 72. Pfizer Menopause Drugs Product

Table 73. Pfizer Revenue in Menopause Drugs Business (2019-2024) & (US$ Million)

Table 74. Pfizer Recent Developments

Table 75. AbbVie Company Details

Table 76. AbbVie Business Overview

Table 77. AbbVie Menopause Drugs Product

Table 78. AbbVie Revenue in Menopause Drugs Business (2019-2024) & (US$ Million)

Table 79. AbbVie Recent Developments

Table 80. Novo Nordisk Company Details

Table 81. Novo Nordisk Business Overview

Table 82. Novo Nordisk Menopause Drugs Product

Table 83. Novo Nordisk Revenue in Menopause Drugs Business (2019-2024) & (US$ Million)

Table 84. Novo Nordisk Recent Developments

Table 85. Merck KGaA Company Details

Table 86. Merck KGaA Business Overview

Table 87. Merck KGaA Menopause Drugs Product

Table 88. Merck KGaA Revenue in Menopause Drugs Business (2019-2024) & (US$ Million)

Table 89. Merck KGaA Recent Developments

Table 90. Viatris Company Details

Table 91. Viatris Business Overview

Table 92. Viatris Menopause Drugs Product

Table 93. Viatris Revenue in Menopause Drugs Business (2019-2024) & (US$ Million)

Table 94. Viatris Recent Developments

Table 95. Bayer Company Details

Table 96. Bayer Business Overview

Table 97. Bayer Menopause Drugs Product

Table 98. Bayer Revenue in Menopause Drugs Business (2019-2024) & (US$ Million)

Table 99. Bayer Recent Developments

Table 100. Teva Company Details

Table 101. Teva Business Overview

Table 102. Teva Menopause Drugs Product

Table 103. Teva Revenue in Menopause Drugs Business (2019-2024) & (US$ Million)

Table 104. Teva Recent Developments

Table 105. Novartis Company Details

Table 106. Novartis Business Overview

Table 107. Novartis Menopause Drugs Product

Table 108. Novartis Revenue in Menopause Drugs Business (2019-2024) & (US$ Million)

Table 109. Novartis Recent Developments

Table 110. Abbott Company Details

Table 111. Abbott Business Overview

Table 112. Abbott Menopause Drugs Product

Table 113. Abbott Revenue in Menopause Drugs Business (2019-2024) & (US$ Million)

Table 114. Abbott Recent Developments

Table 115. Roche Company Details

Table 116. Roche Business Overview

Table 117. Roche Menopause Drugs Product

Table 118. Roche Revenue in Menopause Drugs Business (2019-2024) & (US$ Million)

Table 119. Roche Recent Developments

Table 120. Endo International Company Details

Table 121. Endo International Business Overview

Table 122. Endo International Menopause Drugs Product

Table 123. Endo International Revenue in Menopause Drugs Business (2019-2024) & (US$ Million)

Table 124. Endo International Recent Developments

Table 125. Ipsen Company Details

Table 126. Ipsen Business Overview

Table 127. Ipsen Menopause Drugs Product

Table 128. Ipsen Revenue in Menopause Drugs Business (2019-2024) & (US$ Million)

Table 129. Ipsen Recent Developments

Table 130. Research Programs/Design for This Report

Table 131. Key Data Information from Secondary Sources

Table 132. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Menopause Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Menopause Drugs Market Share by Type: 2023 VS 2030

Figure 3. Parenteral Features

Figure 4. Transdermal Features

Figure 5. Oral Features

Figure 6. Others Features

Figure 7. Global Menopause Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 8. Global Menopause Drugs Market Share by Application: 2023 VS 2030

Figure 9. Hospitals Case Studies

Figure 10. Drugstores Case Studies

Figure 11. Others Case Studies

Figure 12. Menopause Drugs Report Years Considered

Figure 13. Global Menopause Drugs Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 14. Global Menopause Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Menopause Drugs Market Share by Region: 2023 VS 2030

Figure 16. Global Menopause Drugs Market Share by Players in 2023

Figure 17. Global Top Menopause Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Menopause Drugs as of 2023)

Figure 18. The Top 10 and 5 Players Market Share by Menopause Drugs Revenue in 2023

Figure 19. North America Menopause Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. North America Menopause Drugs Market Share by Type (2019-2030)

Figure 21. North America Menopause Drugs Market Share by Application (2019-2030)

Figure 22. North America Menopause Drugs Market Share by Country (2019-2030)

Figure 23. United States Menopause Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Canada Menopause Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Menopause Drugs Market Size YoY (2019-2030) & (US$ Million)

Figure 26. Europe Menopause Drugs Market Share by Type (2019-2030)

Figure 27. Europe Menopause Drugs Market Share by Application (2019-2030)

Figure 28. Europe Menopause Drugs Market Share by Country (2019-2030)

Figure 29. Germany Menopause Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. France Menopause Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. U.K. Menopause Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Italy Menopause Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Russia Menopause Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Nordic Countries Menopause Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. China Menopause Drugs Market Size YoY (2019-2030) & (US$ Million)

Figure 36. China Menopause Drugs Market Share by Type (2019-2030)

Figure 37. China Menopause Drugs Market Share by Application (2019-2030)

Figure 38. Asia Menopause Drugs Market Size YoY (2019-2030) & (US$ Million)

Figure 39. Asia Menopause Drugs Market Share by Type (2019-2030)

Figure 40. Asia Menopause Drugs Market Share by Application (2019-2030)

Figure 41. Asia Menopause Drugs Market Share by Region (2019-2030)

Figure 42. Japan Menopause Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. South Korea Menopause Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. China Taiwan Menopause Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Southeast Asia Menopause Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. India Menopause Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Australia Menopause Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Middle East, Africa, and Latin America Menopause Drugs Market Size YoY (2019-2030) & (US$ Million)

Figure 49. Middle East, Africa, and Latin America Menopause Drugs Market Share by Type (2019-2030)

Figure 50. Middle East, Africa, and Latin America Menopause Drugs Market Share by Application (2019-2030)

Figure 51. Middle East, Africa, and Latin America Menopause Drugs Market Share by Country (2019-2030)

Figure 52. Brazil Menopause Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 53. Mexico Menopause Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Turkey Menopause Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. Saudi Arabia Menopause Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. Israel Menopause Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 57. GCC Countries Menopause Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 58. Eli Lilly Revenue Growth Rate in Menopause Drugs Business (2019-2024)

Figure 59. Pfizer Revenue Growth Rate in Menopause Drugs Business (2019-2024)

Figure 60. AbbVie Revenue Growth Rate in Menopause Drugs Business (2019-2024)

Figure 61. Novo Nordisk Revenue Growth Rate in Menopause Drugs Business (2019-2024)

Figure 62. Merck KGaA Revenue Growth Rate in Menopause Drugs Business (2019-2024)

Figure 63. Viatris Revenue Growth Rate in Menopause Drugs Business (2019-2024)

Figure 64. Bayer Revenue Growth Rate in Menopause Drugs Business (2019-2024)

Figure 65. Teva Revenue Growth Rate in Menopause Drugs Business (2019-2024)

Figure 66. Novartis Revenue Growth Rate in Menopause Drugs Business (2019-2024)

Figure 67. Abbott Revenue Growth Rate in Menopause Drugs Business (2019-2024)

Figure 68. Roche Revenue Growth Rate in Menopause Drugs Business (2019-2024)

Figure 69. Endo International Revenue Growth Rate in Menopause Drugs Business (2019-2024)

Figure 70. Ipsen Revenue Growth Rate in Menopause Drugs Business (2019-2024)

Figure 71. Bottom-up and Top-down Approaches for This Report

Figure 72. Data Triangulation

Figure 73. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Vaginal Rings Market Insights, Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-33R9636

Fri Dec 27 00:00:00 UTC 2024

Add to Cart

Global Pediatric Cervical Collars Market Insights, Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-19O9405

Tue Dec 17 00:00:00 UTC 2024

Add to Cart

Global Menopause Drugs Market Insights, Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-35S9174

Tue Dec 17 00:00:00 UTC 2024

Add to Cart

Postpartum Product - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-5U10006

Wed Dec 04 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions